Mortality Risk in Hemodiafiltration vs. Hemodialysis: DOPPS European Findings
This presentation explores the mortality risk associated with hemodiafiltration compared to conventional hemodialysis, using data from the DOPPS study across Europe. We examine crude patient characteristics by dialysis type, present adjusted intermediate outcomes, and analyze relative mortality risks. The findings illustrate the potential benefits of hemodiafiltration and provide valuable insights for clinical practice in managing patients with end-stage renal disease.
Mortality Risk in Hemodiafiltration vs. Hemodialysis: DOPPS European Findings
E N D
Presentation Transcript
Mortality Risk for Patients Receiving Hemodiafiltration versus Hemodialysis: European Results from the DOPPS
Crude Patient Characteristics by Dialysis Type (mean or %)* (1)
Crude Patient Characteristics by Dialysis Type (mean or %)* (2)
Crude Patient Characteristics by Dialysis Type (mean or %)* (3)
Crude Patient Characteristics by Dialysis Type (mean or %)* (4)
Crude Patient Characteristics by Dialysis Type (mean or %)* (5)
Adjusted* Intermediate Outcomes by Dialysis Type (p-value vs. Low-flux HD) (1)
Adjusted* Intermediate Outcomes by Dialysis Type (p-value vs. Low-flux HD) (2)